Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17298645 | 0.93 | KDM4E (0.37) | KDM4EATML3MBTL1 | |
| SCHEMBL11922055 | 0.93 | KDM4E (0.37) | KDM4EATML3MBTL1 | |
| SCHEMBL15138662 | 0.90 | KDM4E (0.39) | KDM4EATML3MBTL1 | |
| SCHEMBL14728176 | 0.89 | KDM4E (0.37) | KDM4EATML3MBTL1 | |
| SCHEMBL16202909 | 0.89 | KDM4E (0.37) | KDM4EATML3MBTL1 | |
| SCHEMBL9916446 | 0.89 | KDM4E (0.33) | KDM4EATML3MBTL1 | |
| SCHEMBL19152087 | 0.89 | KDM4E (0.33) | KDM4EATML3MBTL1 | |
| SCHEMBL22301980 | 0.89 | KDM4E (0.35) | KDM4EATML3MBTL1 | |
| SCHEMBL12704802 | 0.88 | KDM4E (0.33) | KDM4EATML3MBTL1 | |
| SCHEMBL17250369 | 0.88 | KDM4E (0.33) | KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9017829-B2 | Phenanthrocarbazole compound, and organic electroluminescent device using same | DOOSAN CORPORATION (KR) | 2015-04-28 | — | — | US | disclosed |
| US-9017829-B2 | Phenanthrocarbazole compound, and organic electroluminescent device using same | DOOSAN CORPORATION (KR) | 2015-04-28 | — | — | US | disclosed |
| US-20130048975-A1 | PHENANTHROCARBAZOLE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | DOOSAN CORPORATION (KR) | 2013-02-28 | — | — | US | disclosed |
| US-20130048975-A1 | PHENANTHROCARBAZOLE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | DOOSAN CORPORATION (KR) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130048975-A1 | PHENANTHROCARBAZOLE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | PPOX, ORC3, CACNA2D3 | KDM4E 1626/4885ATM 4087/4885L3MBTL1 2318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.